Human Mutation · 2013 · 14 citations · 14 references
Life SciencesGeneticsMolecular GeneticsHuman GeneticsMedical GeneticsNeoplasiaCyclin-dependent KinasesEndocrine Tumor GeneticsGenetic DisordersHereditary Cancer SyndromesInherited Endocrine SyndromesMultiple Endocrine NeoplasiaCancer-associated Cyclin-dependent KinasesCdkn1b Gene MutationsCyclin-dependent Kinase DysregulationCyclin-dependent Kinase RegulationDevelopmental Delay GeneticsHereditary Endocrine Tumor SyndromesKinase Inhibitor ProteinsRecessive Inheritance Models
Germline mutations in the cyclin-dependent kinase inhibitor, CDKN1B, have been described in patients with multiple endocrine neoplasia (MEN), a cancer predisposition syndrome with adult onset neoplasia and no additional phenotypes. Here, we describe the first human case of CDKN1B deficiency, which recapitulates features of the murine CDKN1B knockout mouse model, including gigantism and neurodevelopmental defects. Decreased mRNA and protein expression of CDKN1B were confirmed in the proband's peripheral blood, which is not seen in MEN syndrome patients. We ascribed the decreased protein level to a maternally derived deletion on chromosome 12p13 encompassing the CDKN1B locus (which reduced mRNA expression) and a de novo allelic variant (c.-73G>A) in the CDKN1B promoter (which reduced protein translation). We propose a recessive model where decreased dosage of CDKN1B during development in humans results in a neuronal phenotype akin to that described in mice, placing CDKN1B as a candidate gene involved in developmental delay.
14
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Hiroaki Kiyokawa, Rhonda D. Kineman, Katia Manova‐Todorova et al. · Cell · 1996 · 1.3K citations · Full text
Cyclin E-CDK2 is a regulator of p27Kip1.
Robert J. Sheaff, Mark Groudine, Michael D. Gordon et al. · Genes & Development · 1997 · 927 citations · Full text